Evidence map›Paper›PMID 36356411›Full record

Trial reportESMO open2022

Effects of a communication training for oncologists on early addressing palliative and end-of-life care in advanced cancer care (PALLI-COM): a randomized, controlled trial.

N Harnischfeger, H M Rath, B Alt-Epping, H Brand, K Haller, A Letsch, N Rieder, P Thuss-Patience, C Bokemeyer, C Bergelt and 1 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in ESMO open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

N HarnischfegerPalliative Care Unit, Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Electronic address: n.harnischfeger@uke.de.
H M RathDepartment of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
B Alt-EppingDepartment of Palliative Medicine, Heidelberg University Hospital, Heidelberg, Germany; Department of Palliative Medicine, University Medical Center Goettingen, Goettingen, Germany.
H BrandDepartment of Hematology, Oncology and Tumor Immunology, Campus Kiel, University Medical Center Schleswig-Holstein, Kiel, Germany.
K HallerDepartment of Hematology, Oncology and Cancer Immunology, Campus Virchow-Klinikum, Charité - University Medicine Berlin, Berlin, Germany.
A LetschDepartment of Hematology, Oncology and Tumor Immunology, Campus Kiel, University Medical Center Schleswig-Holstein, Kiel, Germany; Department of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - University Medicine Berlin, Berlin, Germany.
N RiederDepartment of Palliative Medicine, Heidelberg University Hospital, Heidelberg, Germany; Department of Palliative Medicine, University Medical Center Goettingen, Goettingen, Germany.
P Thuss-PatienceDepartment of Hematology, Oncology and Cancer Immunology, Campus Virchow-Klinikum, Charité - University Medicine Berlin, Berlin, Germany.
C BokemeyerPalliative Care Unit, Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
C BergeltDepartment of Medical Psychology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Medical Psychology, University Medicine Greifswald, Greifswald, Germany.
K OechslePalliative Care Unit, Department of Oncology, Hematology and BMT, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
University Medical Center Hamburg-Eppendorf · DECharité - Universitätsmedizin Berlin · DEKiel University · DEHeidelberg University · DEUniversität Hamburg · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn advanced cancer care, early communication about palliative care (PC) and end-of-life (EoL)-related issues is recommended, but is often impeded by physicians' communication insecurities. We investigated the effect of a newly developed compact communication skills training 'PALLI-COM' on oncologists' competencies to early address PC/EoL-related issues. MATERIALS AND

methodsWe conducted a randomized, controlled trial (RCT) with an intervention group (IG; 2 × 90 min training) and a wait list control group (CG) at five sites. At two assessment points, participating oncologists led videotaped medical consultations with simulated patients (SPs) via a privacy compliant video conference platform. SPs were represented by trained actors. The taped conversations were rated for primary outcome (communication skills assessed by adapted COM-ON-checklist and COM-ON-coaching rating scales) by raters blinded for study group. Secondary outcomes included oncologists' self-reported communication skills (Self-Efficacy in Palliative Care Scale, Thanatophobia-Scale, Communication about End of Life Survey, study-specific items) as well as external rating of the SPs. Univariate analyses of covariance with baseline adjustment were used to analyze intervention effects.

resultsA total of 141 oncologists [age: mean (standard deviation) = 32.7 (6.3) years, 60% female (n

conclusionFindings indicate that the compact communication skills training PALLI-COM increases oncologists' competencies in early addressing PC/EoL-related issues from different perspectives. Implementation in routine oncology residency might improve advanced cancer care by strengthening these communication skills.

Indexed as

NeoplasmsOncologistsTerminal CareAdultCommunicationFemaleHumansMalePalliative Carecommunication skills trainingcontrolled trialoncologypalliative carerandomizedsupportive care

Identifiers

PMID36356411
PMCPMC9808464
OpenAlexW4308429171

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.